journal article·2025-09-09Open access

Impact of 45S5-Bioactive Glass on Chondrocytes in Knee Osteoarthritis—In Vitro Study Exploring Cellular Responses

Max Marinescu, Sébastien Hagmann, Jörg Fellenberg, Elena Tripel, Simone Gantz, Ravikumar Mayakrishnan, Aldo R. Boccaccini, Tobias Renkawitz, Babak Moradi, Fabian Westhauser, Hadrian Platzer

Abstract

Osteoarthritis (OA), the most common joint disease, is marked by cartilage degradation and chronic inflammation. While 45S5-bioactive glass (45S5-BG) is well-established in bone regeneration and has been suggested to exert immunomodulatory effects, its impact on OA chondrocytes remains largely unexplored. Therefore, this in vitro study investigated the effects of 45S5-BG microparticles (0.125 mg/mL) on chondrocytes derived from OA patients, evaluating its therapeutic potential in OA. Chondrocytes were cultured with or without 45S5-BG for 1 and 7 days. Gene expression of cartilage markers, cytokines, matrix metalloproteinases (MMPs), and toll-like receptors (TLRs) was analyzed by qPCR. Protein levels were assessed by ELISA. 45S5-BG stimulation significantly altered chondrocyte activity, inducing upregulation of IL-6, IL-1β, TNF-α, MMP-1/-3/-13, and TLR4. Expression of ACAN and COL2A1 was reduced, while COL10A1—a marker of chondrocyte hypertrophy—was significantly increased at day 1. These findings show a catabolic and pro-inflammatory shift in chondrocyte phenotype upon 45S5-BG exposure, showing no therapeutic benefit of 45S5-BG on OA chondrocytes. However, considering the pronounced effects on chondrocyte activity and the well-established bioactivity and biocompatibility of 45S5-BG, our findings suggest that modified BG formulations could be developed to enhance chondroprotective and anti-inflammatory properties, warranting further investigation in co-culture and in vivo models.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Bone Tissue Engineering Materials · Spine and Intervertebral Disc Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany

Orthopedic Research Center, Kiel University, 24118 Kiel, Germany

Institute of Biomaterials, University of Erlangen-Nuremberg, 91085 Erlangen, Germany

Department of Orthopaedics, University of Regensburg, Asklepios Klinikum Bad Abbach, 93077 Bad Abbach, Germany

Department of Orthopedics and Trauma Surgery, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany

Funding

Research Fund of the Heidelberg Orthopaedic University Hospital and Deutsche Arthrose-Hilfe e.V.

References (70)

Show source-provided references
2. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)10.1016/j.joca.2012.11.012 ↗
3. Epidemiology of osteoarthritis: Literature update10.1097/BOR.0000000000000479 ↗
4. Inflammation in osteoarthritis: Our view on its presence and involvement in disease development over the years10.1016/j.joca.2023.12.005 ↗
5. Yunus, M.H.M., Nordin, A., and Kamal, H. (2020). Pathophysiological Perspective of Osteoarthritis. Medicina, 56.10.3390/medicina56110614 ↗
6. Synovitis and the risk of knee osteoarthritis: The MOST Study10.1016/j.joca.2015.09.013 ↗
7. Impact of Mononuclear Cell Infiltration on Chondrodestructive MMP/ADAMTS Production in Osteoarthritic Knee Joints-An Ex Vivo Study10.3390/jcm9051279 ↗
8. Articular cartilage degradation in osteoarthritis10.1007/s11420-011-9250-z ↗
9. Krakowski, P., Rejniak, A., Sobczyk, J., and Karpiński, R. (2024). Cartilage Integrity: A Review of Mechanical and Frictional Properties and Repair Approaches in Osteoarthritis. Healthcare, 12.10.3390/healthcare12161648 ↗
10. Disease-modifying therapeutic strategies in osteoarthritis: Current status and future directions10.1038/s12276-021-00710-y ↗
11. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date10.2147/DDDT.S295224 ↗
12. The story of Bioglass10.1007/s10856-006-0432-z ↗
13. Cannio, M., Bellucci, D., Roether, J.A., Boccaccini, D.N., and Cannillo, V. (2021). Bioactive Glass Applications: A Literature Review of Human Clinical Trials. Materials, 14.10.3390/ma14185440 ↗
14. Trends and perspectives on the commercialization of bioactive glasses10.1016/j.actbio.2023.02.020 ↗
15. Fellenberg, J., Losch, S., Marinescu, M.R., Frey, B., Lehner, B., Arango-Ospina, M., Hadzhieva, Z., Boccaccini, A.R., and Westhauser, F. (2023). Bioactive Glass Inhibits Tumor Development from Giant Cell Tumor of Bone-Derived Neoplastic Stromal Cells in a Chicken Chorioallantoic Membrane Assay. Cancers, 15.10.3390/cancers15061868 ↗
16. Drago, L., Toscano, M., and Bottagisio, M. (2018). Recent Evidence on Bioactive Glass Antimicrobial and Antibiofilm Activity: A Mini-Review. Materials, 11.10.3390/ma11020326 ↗
17. Fiume, E., Barberi, J., Verné, E., and Baino, F. (2018). Bioactive Glasses: From Parent 45S5 Composition to Scaffold-Assisted Tissue-Healing Therapies. J. Funct. Biomater., 9.10.3390/jfb9010024 ↗
18. Bioactive Glasses: A Promising Therapeutic Ion Release Strategy for Enhancing Wound Healing10.1021/acsbiomaterials.0c00528 ↗
19. Skallevold, H.E., Rokaya, D., Khurshid, Z., and Zafar, M.S. (2019). Bioactive Glass Applications in Dentistry. Int. J. Mol. Sci., 20.10.3390/ijms20235960 ↗
20. Borges, R., Pelosine, A.M., de Souza, A.C.S., Machado, J., Justo, G.Z., Gamarra, L.F., and Marchi, J. (2022). Bioactive Glasses as Carriers of Cancer-Targeted Drugs: Challenges and Opportunities in Bone Cancer Treatment. Materials, 15.10.3390/ma15249082 ↗
21. Bioactive glasses in wound healing: Hope or hype?10.1039/C7TB01221G ↗
22. Zheng, K., Torre, E., Bari, A., Taccardi, N., Cassinelli, C., Morra, M., Fiorilli, S., Vitale-Brovarone, C., Iviglia, G., and Boccaccini, A.R. (2020). Antioxidant mesoporous Ce-doped bioactive glass nanoparticles with anti-inflammatory and pro-osteogenic activities. Mater. Today Bio., 5.10.1016/j.mtbio.2020.100041 ↗
23. Hammami, I., Gavinho, S.R., Jakka, S.K., Valente, M.A., Graça, M.P.F., Pádua, A.S., Silva, J.C., Sá-Nogueira, I., and Borges, J.P. (2023). Antibacterial Biomaterial Based on Bioglass Modified with Copper for Implants Coating. J. Funct. Biomater., 14.10.3390/jfb14070369 ↗
24. Ciołek, L., Zaczyńska, E., Krok-Borkowicz, M., Biernat, M., and Pamuła, E. (2024). Chitosan and Sodium Hyaluronate Hydrogels Supplemented with Bioglass for Bone Tissue Engineering. Gels, 10.10.3390/gels10020128 ↗
25. Gavinho, S.R., Pádua, A.S., Holz, L.I.V., Sá-Nogueira, I., Silva, J.C., Borges, J.P., Valente, M.A., and Graça, M.P.F. (2023). Bioactive Glasses Containing Strontium or Magnesium Ions to Enhance the Biological Response in Bone Regeneration. Nanomaterials, 13.10.3390/nano13192717 ↗
26. Green Electrospun Poly(vinyl alcohol)/Gelatin-Based Nanofibrous Membrane by Incorporating 45S5 Bioglass Nanoparticles and Urea for Wound Dressing Applications: Characterization and In Vitro and In Vivo Evaluations10.1021/acsomega.4c01102 ↗
27. Synthesis and characterization of barium-doped bioactive glass with potential anti-inflammatory activity10.1016/j.ceramint.2020.11.068 ↗
28. The effect of the topical administration of bioactive glass on inflammatory markers of human experimental gingivitis10.1016/j.biomaterials.2004.05.005 ↗
29. Effect of particulate bioactive glasses on human macrophages and monocytes in vitro10.1002/jbm.a.30262 ↗
30. Platzer, H., Marinescu, M., Nawaz, Q., Tripel, E., Gantz, S., Horsch, A., Daniel, V., Boccaccini, A.R., Hagmann, S., and Moradi, B. (2023). The Impact of 45S5-Bioactive Glass on Synovial Cells in Knee Osteoarthritis-An In Vitro Study. Materials, 16.10.3390/ma16247594 ↗
31. Xue, K., Zhang, S., Ge, J., Wang, Q., Qi, L., and Liu, K. (2022). Integration of Bioglass Into PHBV-Constructed Tissue-Engineered Cartilages to Improve Chondrogenic Properties of Cartilage Progenitor Cells. Front. Bioeng. Biotechnol., 10.10.3389/fbioe.2022.868719 ↗
32. Subchondral bone and cartilage repair with bioactive glasses, hydroxyapatite, and hydroxyapatite-glass composite10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.0.CO;2-R ↗
33. The modulation of tissue-specific gene expression in rat nasal chondrocyte cultures by bioactive glasses10.1016/j.biomaterials.2004.01.016 ↗
34. Matrix metalloproteinases: Role in arthritis10.2741/1817 ↗
35. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage10.1186/ar2013 ↗
36. High MMP-1, MMP-2, and MMP-9 protein levels in osteoarthritis10.4238/2015.November.18.46 ↗
37. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review10.1016/j.lfs.2019.116786 ↗
38. Pro-inflammatory IL-1beta and/or TNF-alpha up-regulate matrix metalloproteases-1 and -3 mRNA in chondrocyte subpopulations potentially pathogenic in osteoarthritis: In situ hybridization studies on a single cell level10.1111/1756-185X.12431 ↗
39. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis10.1155/2014/561459 ↗
40. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis10.1002/art.1780380204 ↗
41. Modulation of human chondrocyte metabolism by recombinant human interferon10.1053/joca.1999.0323 ↗
42. Osteoarthritis: Pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
43. Li, T., Peng, J., Li, Q., Shu, Y., Zhu, P., and Hao, L. (2022). The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis. Biomolecules, 12.10.3390/biom12070959 ↗
44. ADAMTS-4 and ADAMTS-5: Key enzymes in osteoarthritis10.1002/jcb.23298 ↗
45. Osteoarthritis year in review 2024: Biology10.1016/j.joca.2024.10.008 ↗
46. The role of aggrecan in normal and osteoarthritic cartilage10.1186/s40634-014-0008-7 ↗
47. The collagens of articular cartilage10.1016/0049-0172(91)90035-X ↗
48. Cell-associated type I collagen in nondegenerate and degenerate human articular cartilage10.1002/jcp.30418 ↗
49. Comparison of the effects of 45S5 and 1393 bioactive glass microparticles on hMSC behavior10.1002/jbm.a.36131 ↗
50. Galusková, D., Kaňková, H., Švančárková, A., and Galusek, D. (2021). Early-Stage Dissolution Kinetics of Silicate-Based Bioactive Glass under Dynamic Conditions: Critical Evaluation. Materials, 14.10.3390/ma14123384 ↗
51. Wilkesmann, S., Westhauser, F., and Fellenberg, J. (2020). Combined Fluorescence-Based in Vitro Assay for the Simultaneous Detection of Cell Viability and Alkaline Phosphatase Activity during Osteogenic Differentiation of Osteoblast Precursor Cells. Methods Protoc., 3.10.3390/mps3020030 ↗
52. Aggrecanase and aggrecan degradation in osteoarthritis: A review10.1177/147323000803600601 ↗
53. Alcaide-Ruggiero, L., Molina-Hernández, V., Granados, M.M., and Domínguez, J.M. (2021). Main and Minor Types of Collagens in the Articular Cartilage: The Role of Collagens in Repair Tissue Evaluation in Chondral Defects. Int. J. Mol. Sci., 22.10.3390/ijms222413329 ↗
54. Partial characterization of cell-type X collagen interactions10.1042/bj20021572 ↗
55. Mixon, A., Bahar-Moni, A.S., and Faisal, T.R. (2022). Mechanical characterization of articular cartilage degraded combinedly with MMP-1 and MMP-9. J. Mech. Behav. Biomed. Mater., 129.10.1016/j.jmbbm.2022.105131 ↗
56. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease10.1016/j.berh.2006.06.007 ↗
57. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates10.1016/S0021-9258(17)39034-8 ↗
58. Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma10.1016/S0021-9258(18)54522-1 ↗
59. Activation of procollagenases is a key control point in cartilage collagen degradation: Interaction of serine and metalloproteinase pathways10.1002/1529-0131(200109)44:9<2084::AID-ART359>3.0.CO;2-R ↗
60. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C ↗
61. A roadmap to target interleukin-6 in osteoarthritis10.1093/rheumatology/keaa248 ↗
62. Immunopathogenesis of osteoarthritis10.1016/j.clim.2012.12.011 ↗
63. The Immunological Facets of Chondrocytes in Osteoarthritis: A Narrative Review10.3899/jrheum.2023-0816 ↗
64. Role of TLR2 and TLR4 in regulation of articular chondrocyte homeostasis10.1016/j.joca.2020.01.011 ↗
65. Barreto, G., Manninen, M., and Eklund, K.K. (2020). Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte Apoptosis. Biology, 9.10.3390/biology9040065 ↗
66. Effects of TLR-2/NF-κB signaling pathway on the occurrence of degenerative knee osteoarthritis: An in vivo and in vitro study10.18632/oncotarget.16199 ↗
67. Sengprasert, P., Waitayangkoon, P., Kamenkit, O., Sawatpanich, A., Chaichana, T., Wongphoom, J., Ngarmukos, S., Taweevisit, M., Lotinun, S., and Tumwasorn, S. (2024). Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus-conditioned media. Sci. Rep., 14.10.1038/s41598-024-68404-9 ↗
68. Copper-incorporated bioactive glass-ceramics inducing anti-inflammatory phenotype and regeneration of cartilage/bone interface10.7150/thno.36120 ↗
69. Sun, H., Zheng, K., Zhou, T., and Boccaccini, A.R. (2021). Incorporation of Zinc into Binary SiO2-CaO Mesoporous Bioactive Glass Nanoparticles Enhances Anti-Inflammatory and Osteogenic Activities. Pharmaceutics, 13.10.3390/pharmaceutics13122124 ↗
70. Gene expression profiles of human chondrocytes during passaged monolayer cultivation10.1002/jor.20523 ↗